Humana Inc. (HUM) stock forecast and price target
Price $450.00 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($450.00)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $9.52 | −44.5% | $162.9B |
| Next fiscal year ends December 31, 2027 | $18.16 | +90.8% | $173.6B |
| Next quarter ends December 31, 2026 | $-7.55 | −90.6% | $41.4B |
| Quarter after ends March 31, 2027 | $13.20 | +28.0% | $43.0B |
Consensus of the analysts covering Humana, updated daily. In the last 30 days 4 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 9.8% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Humana’s intrinsic value about 15% above today’s market value, and it scores 2.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Humana stock price target?
The average 12-month target from 24 analysts is $494.25, 9.8% above the current price of $450.00 Targets range from $280.00 to $602.00.
Is Humana a buy according to analysts?
The consensus rating is “Buy” (3 strong buy, 13 buy, 9 hold, 1 sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Humana expected to earn?
Analysts expect EPS of $9.52 for the fiscal year ending December 31, 2026 and $18.16 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.